ERBB2 and gastric cancer: When HER-2 status was characterized by histological subtype, HER-2 positivity was most common in the intestinal subtype of GC, which is in line with that reported in previous studies.66,67 Interestingly, 91.7% of diffuse HER-2–positive tumors were PD-L1 positive.